Associations of age-related macular degeneration and statin use: a cross-sectional analysis
Authors:
- Abu Bakar ButtABAbu Bakar Butt
- Thuvaraha JeyakumaranTJThuvaraha Jeyakumaran
- Chris ZajnerCZChris Zajner
- Marko M. PopovicMPMarko M. Popovic
- Peter J. KertesPKPeter J. Kertes
- Rajeev H. MuniRMRajeev H. Muni
- Radha P. KohlyRKRadha P. Kohly
- 2 July 2026
- journal article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (5) , 1272-1279
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2025
- Association Between Sociodemographic Factors and Vision Difficulty in the National Health Interview Survey: A Population-Based AnalysisAmerican Journal of Ophthalmology, 2023
- Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular DegenerationJAMA Ophthalmology, 2021
- Targeting Tissue Lipids in Age-related Macular DegenerationEBioMedicine, 2016
- Statins for age-related macular degeneration2012
- Recent Statin Use and 1-Year Incidence of Exudative Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2010
- Four-Year Incidence and Progression of Age-Related Macular Degeneration: The Los Angeles Latino Eye StudyAmerican Journal of Ophthalmology, 2010
- Statin Use and the Incidence of Advanced Age-related Macular Degeneration in the Complications of Age-related Macular Degeneration Prevention TrialOphthalmology, 2009
- Fifteen-Year Cumulative Incidence of Age-Related Macular DegenerationOphthalmology, 2007
- Under-use of smoking-cessation treatmentsAmerican Journal of Preventive Medicine, 2005